CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis
Open Access
- 1 August 2011
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 79 (8) , 3328-3337
Abstract
Convincing correlates of protective immunity against tuberculosis have been elusive. In BALB/c mice, intranasal immunization with a replication-deficient recombinant adenovirus expressing Mycobacterium tuberculosis antigen 85A (adenovirus-85A) induces protective lower respiratory tract immunity against pulmonary challenge with Mycobacterium tuberculosis , while intradermal immunization with adenovirus-85A does not. Here we report that intranasal immunization with adenovirus-85A induces expression of the chemokine receptor CXCR6 on lung CD8 T lymphocytes, which is maintained for at least 3 months. CXCR6-positive antigen-specific T cell numbers are increased among bronchoalveolar lavage-recoverable cells. Similarly, intranasal immunization with recombinant antigen 85A with adjuvant induces CXCR6 expression on lung CD4 cells in BALB/c and C57BL/6 mice, while a synthetic ESAT6 1–20 peptide with adjuvant induces CXCR6 expression in C57BL/6 mice. Parenteral immunization fails to do so. Upregulation of CXCR6 is accompanied by a transient elevation of serum CXCL16 after intranasal immunization, and lung cells cultured ex vivo from mice immunized intranasally show increased production of CXCL16. Administration of CXCL16 and cognate antigen intranasally to mice previously immunized parenterally increases the number of antigen-specific T lymphocytes in the bronchoalveolar lavage-recoverable population, which mediates inhibition of the early growth of Mycobacterium tuberculosis after challenge. We conclude that expression of CXCR6 on lung T lymphocytes is a correlate of local protective immunity against Mycobacterium tuberculosis after intranasal immunization and that CXCR6 and CXCL16 play an important role in the localization of T cells within lung tissue and the bronchoalveolar lavage-recoverable compartment.Keywords
This publication has 55 references indexed in Scilit:
- Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaquesProceedings of the National Academy of Sciences, 2010
- Analysis of CD161 expression on human CD8+T cells defines a distinct functional subset with tissue-homing propertiesProceedings of the National Academy of Sciences, 2010
- A novel method for isolation of human lung T cells from lung resection tissue reveals increased expression of GAPDH and CXCR6Journal of Immunological Methods, 2009
- Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeysProceedings of the National Academy of Sciences, 2009
- THE CHEMOKINE CXCL16 IS HIGHLY AND CONSTITUTIVELY EXPRESSED BY HUMAN BRONCHIAL EPITHELIAL CELLSExperimental Lung Research, 2009
- T lymphocytes in acute bacterial infection: increased prevalence of CD11b+ cells in the peripheral blood and recruitment to the infected siteImmunology, 2008
- Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infectionsClinical and Experimental Immunology, 2008
- ESAT-6-specific CD4 T cell responses to aerosolMycobacterium tuberculosisinfection are initiated in the mediastinal lymph nodesProceedings of the National Academy of Sciences, 2008
- CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markersImmunobiology, 2008
- Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosisProceedings of the National Academy of Sciences, 2007